Astellas 2012 First Quarter Lipitor Sales Down 30%
This article was originally published in PharmAsia News
Executive Summary
Astellas announced its first quarter results, and domestic sales of Lipitor, which Astellas produces for Pfizer in Japan, decreased 32.8% as prices of the drug were decreased by 11% when it launched as a generic drug in November 2011.